Neuble AI Co., Ltd. is a South Korean startup based in Seoul that develops artificial intelligence-based diagnostic and analysis software solutions for brain diseases.
Subscribe to see Neuble AI’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Neuble AI is a decision/risk analysis company headquartered in South Korea. Its most recent funding round, Seed, raised $269,000 in July 2026. Xcout tracks 2 named people at Neuble AI, including 김지훈 (대표자).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $269,000 | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Neuble AI's closest competitors — see the full list of competitors and alternatives →
Aiberry Inc. is a technology company headquartered in Bellevue, Washington, that provides software and screening tools leveraging digital health and artificial intelligence.
RebuilderAI is a South Korean technology company headquartered in Seoul that develops AI-powered 3D content creation and scanning software solutions for mobile devices and e-commerce.
Neurable Inc. is a Boston-based neurotechnology company specializing in AI-powered tools for brain signal translation, including integrated neurotechnology gaming headsets.
1ST Biotherapeutics is a South Korean biopharmaceutical company focused on discovering and developing treatments for neurodegenerative and other central nervous system diseases. Its work is aimed at patients with disorders such as Alzheimer’s disease and related conditions.
Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating small molecule therapeutics utilizing targeted protein degradation technology for novel drug discovery.
Gray Matter Solutions Pte. Ltd. is a Singapore-based MedTech spin-off from Nanyang Technological University's LKCMedicine. Headquartered in Singapore, the company develops registered software medical devices focused on early cognitive decline detection. It provides advanced digital health solutions targeted at neurological assessment and care.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.